• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·MMED
Held by 2 Gurus
Share

MiniMed Group, Inc. Common Stock Stocks

$ 19.1Last Updated 03.08.2026

Issuer Rating

2/7
Performance

Poor

Risk

Limited

Recommendation

Sell

Market Cap

$ 5.07B

$ 19.1
Key Takeaways

Risk factor

Meaningful price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Steven Cohen

Portfolio Weight (%)

0.0%

Change

+0.02%

Fund

Point72 Asset Management, L.P.

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

+0.01%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Steven CohenPoint72 Asset Management, L.P.0.0%+0.02%
Kenneth GriffinCITADEL ADVISORS LLC0.0%+0.01%

Latest news

08.03.2026 22:00

Vendor placement for Patriot, record PayPay listing: what's important about IPOs by March 8

06.03.2026 15:00

MiniMed IPO: diabetes monitoring device maker goes public

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

04.08.2026 19:58

Snap's stock soared: the company expects sales to rise ahead of the launch of its AR glasses

04.08.2026 19:01

Palantir shares jumped 22% at the opening bell following a strong earnings report

04.08.2026 18:05

The "explosive" rise in gold prices is not over — Deutsche Bank

04.08.2026 17:32

The U.S. and Iran May Reach a Deal on the Strait of Hormuz in the Coming Days — Bessent

04.08.2026 16:30

Williams Trading downgrades Birkenstock as brand 'may be losing premium positioning'

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026